Clinical Trials Logo

Hypogonadism clinical trials

View clinical trials related to Hypogonadism.

Filter by:

NCT ID: NCT03747003 Completed - Clinical trials for Erectile Dysfunction

Gonadal Function in Young to Middle Aged HIV-infected Men

Start date: May 15, 2013
Phase:
Study type: Observational

HIV infection is associated to premature decline of serum testosterone. However, prevalence and biochemical characterization of hypogonadism in HIV-infected men are still to be well defined. HIV-infection is strongly associated to erectile dysfunction in men, but preliminary data suggest that it is poorly associated with serum testosterone in this context.

NCT ID: NCT03619330 Completed - Obesity Clinical Trials

Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism.

Start date: December 2014
Phase: Phase 4
Study type: Interventional

The purpose of this study was to compare the effects of liraglutide and testosterone replacement therapy on features of hypogonadism and weight loss in obese men with persistent features of hypogonadism after unsuccessful lifestyle measures.

NCT ID: NCT03541395 Completed - Hypogonadism, Male Clinical Trials

Testosterone-Dependent Effects on Protein Biomarkers From Healthy Males

Start date: March 2015
Phase: N/A
Study type: Interventional

The study is designed to identify and validate new protein biomarkers in blood related to testosterone activity. Thirty healthy young males underwent pharmaceutical castration to lower testosterone levels. After three weeks the subjects received an intramuscular injection of testosterone undecanoate. Blood samples from just before pharmaceutical castration, three weeks after castration, and one week after injection of testosterone undecanoate were collected representing normal testosterone levels, low testosterone levels, and testosterone at eugonadal levels.

NCT ID: NCT03518034 Completed - Clinical trials for Cardiovascular Diseases

A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men

TRAVERSE
Start date: May 3, 2018
Phase: Phase 4
Study type: Interventional

This is a double-blinded and placebo-controlled study of topical testosterone replacement therapy (TRT) in symptomatic hypogonadal men with pre-existing cardiovascular disease (CVD) or increased risk for CVD.

NCT ID: NCT03484260 Completed - Hypogonadism Clinical Trials

Association Between the Prevalence of Cardiovascular Risk Factors and New Use of Testosterone

Start date: April 1, 2018
Phase:
Study type: Observational

We will investigate if testosterone is preferentially given to patients at higher risk of cardiovascular events. If this is the case, then observational studies may be prone to selection bias resulting in overestimation of the cardiovascular risk associated with testosterone when compared to a healthier population not taking testosterone

NCT ID: NCT03437109 Completed - Hypogonadism Clinical Trials

Efficacy of Androgen Substitution for Hypogonadism in Men With Type 2 Diabetes Mellitus

DESTINY
Start date: December 6, 2017
Phase:
Study type: Observational

The purpose of the study is to get data of prevalence of testosterone deficiency in patient with T2DM in Russian Federation

NCT ID: NCT03418896 Completed - Hypogonadism Clinical Trials

Extragonadal Effects of hCG on Calcium Homeostasis

Start date: January 6, 2018
Phase: Phase 1
Study type: Interventional

A pilot study showed that serum calcium levels and calcium homeostasis change in response to hCG stimulation test. Serum calcium level differed when comparing pretreatment values at baseline with serum levels 72 hours after hCG stimulation in men with gonadal insufficiency referred for this stimulation test. Now we want to investigate whether this change in calcium is due to renal loss or other mechanisms and how the classical regulators of calcium homeostasis respond to hCG in men with impaired gonadal function compared with men having normal gonadal function. Moreover, the observed change in serum calcium implies that hCG also changes Phosphate, PTH and calcitonin and this will be clarified with this study

NCT ID: NCT03282682 Completed - Physical Activity Clinical Trials

Strength Training as a Supplemental Therapy of Androgen Deficiency of the Aging Male

Start date: October 1, 2017
Phase: N/A
Study type: Interventional

This study examines the effect of 12-week strength training program with and without testosterone replacement therapy (TRT) on body composition, physical function, selected biochemical markers of metabolic health, molecular parameters of training adaptation and the quality of life patients with ADAM. The investigators believe, that strength training program performed 2 times per week for 12 weeks can improve body composition (decrease fat mass and gain lean mass), muscle strength, muscle power and general quality of life in all training groups. In addition, combination TRT and strength training could help decrease fat mass, improve BMI, cardio-respiratory fitness and thus provide optimal therapy combination for hypogonadal ageing males.

NCT ID: NCT03256292 Completed - Aging Clinical Trials

Long-term Lifestyle Change and Testosterone Replacement

LITE
Start date: August 21, 2017
Phase:
Study type: Observational

Older hypogonadal obese veterans previously participated in a 6 month lifestyle change (diet-induced weight loss and exercise) study with or without testosterone replacement therapy before being followed for the following year at the clinic while receiving standard of care consisting of diet and exercise counseling (for healthy lifestyle change) and testosterone replacement therapy. This study will determine if long-term lifestyle change and testosterone replacement therapy with associated improvement in physical and metabolic health can be maintained in obese older adults.

NCT ID: NCT03254641 Completed - Hypogonadism, Male Clinical Trials

Calciotropic Effects After hCG Stimulation Test

Start date: April 1, 2017
Phase:
Study type: Observational

We have in a pilot study found that serum calcium levels change in response to hCG stimulation test. We observed that serum calcium level measured at baseline and 72 hours after hCG stimulation were different in men with gonadal insufficiency referred for this stimulation test. Now we want to investigate a large cohort of men referred for hCG stimulation test due to suspected impaired gonadal function.